Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Su-Nam | - |
dc.contributor.author | Choi, Hye Young | - |
dc.contributor.author | Lee, Woojung | - |
dc.contributor.author | Park, Gab Man | - |
dc.contributor.author | Shin, Woon Seob | - |
dc.contributor.author | Kim, Yong Kee | - |
dc.date.accessioned | 2024-01-20T22:32:40Z | - |
dc.date.available | 2024-01-20T22:32:40Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2008-10-15 | - |
dc.identifier.issn | 0014-5793 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/133052 | - |
dc.description.abstract | We screened active compounds from natural marine products able to increase PPAR alpha/gamma transcriptional activity. Sargaquinoic acid (SQA) and sargahydroquinoic acid (SHQA) from Sargassum yezoense were identified as novel PPAR alpha/gamma dual agonists. The binding affinity of SQA with PPAR gamma was higher than that of the specific PPAR gamma agonist troglitazone, leading to an activation of PPAR gamma transcriptional activity. In parallel, treatment of 3T3-L1 cells with SQA and SHQA led to an increase in adipocyte differentiation and increased expression of adipogenic marker genes such as aP2, PPAR gamma, resistin, adiponectin, C/EBP alpha and Glut4. Collectively, our data suggest that SQA and SHQA are novel PPAR alpha/gamma dual agonists and may be beneficial for reducing insulin resistance through regulation of adipogenesis. | - |
dc.language | English | - |
dc.publisher | WILEY | - |
dc.subject | PEROXISOME PROLIFERATOR | - |
dc.subject | MARINE PHARMACOLOGY | - |
dc.subject | SIGNALING PATHWAYS | - |
dc.subject | DUAL AGONISTS | - |
dc.subject | RECEPTOR | - |
dc.subject | ATHEROSCLEROSIS | - |
dc.subject | MECHANISMS | - |
dc.title | Sargaquinoic acid and sargahydroquinoic acid from Sargassum yezoense stimulate adipocyte differentiation through PPAR alpha/gamma activation in 3T3-L1 cells | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.febslet.2008.09.011 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | FEBS LETTERS, v.582, no.23-24, pp.3465 - 3472 | - |
dc.citation.title | FEBS LETTERS | - |
dc.citation.volume | 582 | - |
dc.citation.number | 23-24 | - |
dc.citation.startPage | 3465 | - |
dc.citation.endPage | 3472 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000260806700036 | - |
dc.identifier.scopusid | 2-s2.0-53049093699 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biophysics | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Biophysics | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | PEROXISOME PROLIFERATOR | - |
dc.subject.keywordPlus | MARINE PHARMACOLOGY | - |
dc.subject.keywordPlus | SIGNALING PATHWAYS | - |
dc.subject.keywordPlus | DUAL AGONISTS | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | ATHEROSCLEROSIS | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordAuthor | PPAR alpha/gamma agonist | - |
dc.subject.keywordAuthor | Sargaquinoic acid | - |
dc.subject.keywordAuthor | Sargahydroquinoic acid | - |
dc.subject.keywordAuthor | Sargassum yezoense | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.